M J Farbstein
Overview
Explore the profile of M J Farbstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Linker C, Levitt L, ODonnell M, Ries C, Link M, Forman S, et al.
Blood
. 1987 Apr;
69(4):1242-8.
PMID: 3470055
We designed a treatment program to improve the outcome for adults with acute lymphoblastic leukemia (ALL). Treatment included a remission-induction phase followed by intensive alternating cycles of non-cross-resistant chemotherapy and...
2.
ODonnell M, Forman S, Levine A, Territo M, Farbstein M, Fahey J, et al.
Cancer Treat Rep
. 1987 Feb;
71(2):187-9.
PMID: 3802114
A phase II trial of cytarabine, cisplatin, and etoposide was conducted in 38 patients with refractory stage III and IV non-Hodgkin's lymphoma. There were two complete and nine partial responses...
3.
Fahey J, Rahbar S, Farbstein M, Forman S, Blume K, Beutler E
Am J Hematol
. 1986 Oct;
23(2):123-9.
PMID: 3752067
A review of 162 patients with Hodgkin disease disclosed 36 with microcytic anemia (mean corpuscular hemoglobin values [MCV] less than 80 fl). Three patients had iron deficiency, and one had...
4.
Forman S, Nathwani B, Woda B, Paladugu R, Farbstein M
Arch Pathol Lab Med
. 1985 Dec;
109(12):1081-4.
PMID: 3878141
We describe a patient with T-cell prolymphocytic leukemia who developed a large-cell lymphoma of the T-cell type. The neoplastic cells of the large-cell lymphoma demonstrated the same immunologic phenotype (ER+,...
5.
Forman S, Nademanee A, ODonnell M, Fahey J, Snyder D, Farbstein M, et al.
Semin Oncol
. 1985 Jun;
12(2 Suppl 3):114-6.
PMID: 4012336
No abstract available.
6.
Outcome of bone marrow transplantation in patients with extramedullary involvement of acute leukemia
Spruce W, Forman S, Krance R, Farbstein M, Wolf J, Scott E, et al.
Blut
. 1984 Feb;
48(2):75-9.
PMID: 6365207
Infiltration of extrahemopoietic tissue with leukemic cells was evaluated as a prognostic indicator in 18 patients with acute leukemia undergoing bone marrow transplantation. When compared to 107 patients who did...
7.
Forman S, Spruce W, Farbstein M, Wolf J, Scott E, Nademanee A, et al.
Blood
. 1983 Mar;
61(3):439-42.
PMID: 6337652
Of 33 patients who had undergone allogeneic bone marrow transplantation during first complete remission of acute nonlymphocytic leukemia, 21 patients have now been followed in continued complete remission for 6-64...
8.
Spruce W, Forman S, Blume K, Farbstein M, Scott E, Wolf J, et al.
Am J Pediatr Hematol Oncol
. 1983 Jan;
5(4):337-40.
PMID: 6367519
Bone marrow transplantation has become the treatment of choice for patients with severe aplastic anemia who are fortunate enough to have allogeneic sibling donors. As patients have been transplanted earlier...
9.
Wolf J, Spruce W, Bearman R, Forman S, Scott E, Fahey J, et al.
Blood
. 1982 Jan;
59(1):191-3.
PMID: 7032626
A 28-yr-old woman with acute malignant myelosclerosis received, as primary treatment, ablative chemotherapy and total body radiation therapy followed by bone marrow transplantation from her histocompatible brother. The patient is...
10.
Blume K, Spruce W, Forman S, Wolf J, Farbstein M, Scott E, et al.
N Engl J Med
. 1981 Jul;
305(2):101-3.
PMID: 7017404
No abstract available.